Cancer Clinical Trial
Official title:
Cancer Center Trials: Reasons for Low Accrual Rates at One Academic Institution Vs. The Community Setting
1. To identify reasons for low patient recruitment numbers to clinical trials in a cancer
research center setting (and a community setting) in order to attempt to increase
accrual rates.
2. To review the screening sheet for women who considered participating in the study of
Tamoxifen and Raloxifene (STAR) for the prevention of breast cancer in high risk women
through the University of New Mexico in Albuquerque from 1999 through 2004
Objective 1: All new cancer patients seen for a four month period at the University of New
Mexico Cancer Research and Treatment Center (UNM CRTC) (academic population) and for a six
month-period at the New Mexico Cancer Care Alliance (NMCCA) (community setting). A careful
screening log will be kept during this period with the research nurses cooperation in
documenting 1) whether patients seen were accrued to a clinical trial, 2) what available
trials the patient might possibly be eligible for, and 3) the reason for not registering on
to a clinical trial.
Objective 2: To compare the responses to questions on the entry forms of those women who
were eligible and declined participation to those who participated by Hispanic versus
non-Hispanic ethnicity, we will access, copy, and analyze all the risk assessment profiles
otherwise known as entry or eligibility forms completed by women who considered
participating in the study of Tamoxifen and Raloxifene (STAR). Patterns of eligibility
criteria and risk assessment will be described by ethnicity of women considered for entry
into this chemopreventive randomized trial without the use of personal identifying data in
accordance with the Health Insurance Portability Accountability Act of 1996 to maintain
patient confidentiality
;
Observational Model: Ecologic or Community, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|